CN112451641A - 一种跌打救苦膏及其制备方法 - Google Patents
一种跌打救苦膏及其制备方法 Download PDFInfo
- Publication number
- CN112451641A CN112451641A CN202011474394.6A CN202011474394A CN112451641A CN 112451641 A CN112451641 A CN 112451641A CN 202011474394 A CN202011474394 A CN 202011474394A CN 112451641 A CN112451641 A CN 112451641A
- Authority
- CN
- China
- Prior art keywords
- parts
- traumatic injury
- raw materials
- blood
- rescuing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014674 injury Diseases 0.000 title claims abstract description 52
- 230000008736 traumatic injury Effects 0.000 title claims abstract description 50
- 239000002674 ointment Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 43
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 17
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 17
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 17
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 17
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 17
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 17
- 241000123589 Dipsacus Species 0.000 claims abstract description 17
- 241000208688 Eucommia Species 0.000 claims abstract description 17
- 239000004863 Frankincense Substances 0.000 claims abstract description 17
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 17
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 17
- 210000003056 antler Anatomy 0.000 claims abstract description 17
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 16
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 16
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 16
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 16
- 244000164480 Curcuma aromatica Species 0.000 claims abstract description 16
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 16
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 16
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 16
- 229940116229 borneol Drugs 0.000 claims abstract description 16
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 16
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000009136 dragon's blood Substances 0.000 claims abstract description 16
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 16
- 235000011477 liquorice Nutrition 0.000 claims abstract description 16
- 239000008159 sesame oil Substances 0.000 claims abstract description 16
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 16
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 16
- 241000411851 herbal medicine Species 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 14
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 10
- 238000004140 cleaning Methods 0.000 claims abstract description 7
- 238000000227 grinding Methods 0.000 claims abstract description 7
- 238000000643 oven drying Methods 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 7
- 238000010298 pulverizing process Methods 0.000 claims abstract description 7
- 238000007873 sieving Methods 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims description 53
- 210000000988 bone and bone Anatomy 0.000 claims description 14
- 241000233866 Fungi Species 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 241000238631 Hexapoda Species 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 29
- 238000011282 treatment Methods 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 4
- 206010005963 Bone formation increased Diseases 0.000 abstract description 2
- 206010034464 Periarthritis Diseases 0.000 abstract description 2
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract description 2
- 208000036319 cervical spondylosis Diseases 0.000 abstract description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 2
- 208000005801 spondylosis Diseases 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 24
- 230000036407 pain Effects 0.000 description 24
- 230000001737 promoting effect Effects 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 230000017531 blood circulation Effects 0.000 description 18
- 230000006870 function Effects 0.000 description 16
- 229940079593 drug Drugs 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 239000011505 plaster Substances 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000004089 microcirculation Effects 0.000 description 7
- 210000002435 tendon Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000003467 diminishing effect Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000002040 relaxant effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 208000037816 tissue injury Diseases 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010018852 Haematoma Diseases 0.000 description 2
- 208000029549 Muscle injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000008338 local blood flow Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000001055 Ischemic Contracture Diseases 0.000 description 1
- 206010023198 Joint ankylosis Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000009854 mucosal lesion Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种跌打救苦膏,包括以下中草药原料:桃仁、红花、生乳香、没药、三棱、莪术、骨碎补、续断、杜仲、当归、白芷、犬片、五加皮、甘草、生地、鸡血藤、血竭、鹿茸、冰片以及麻油;制备方法包括以下步骤:将原料经过清洗,烘干工艺,在无菌、无尘的条件下,用中药粉碎机将中草药分别磨碎,用120目筛进行筛分,按配比掺和混均,研磨成粉状后,再混合搅拌均匀制成软膏即可;本发明使用方便,疗效稳定,治疗彻底,无任何毒副作用。跌打救育膏是用二十多种中草药精制而成,主要用于治疗跌打损伤、肩周炎、颈椎病、胶间盘突出、骨质增生、风湿、类风湿性关节炎等疾病。
Description
技术领域
本发明涉及一种治疗跌打损伤的外用药物,具体地说是以中草药为原料制备的中成药,特别涉及一种跌打救苦膏及其制备方法。
背景技术
中医认为跌打损伤致软组织肿痛属于“筋伤"范畴,可发生在任何年龄阶段的人,现在社会多是长期劳损出现组织损伤,如跌打损伤而置之不理,就会形成淤血堆积。
现有的治疗存在以下不足:一是治疗时间长花费多,二是错过了早日康复的良机。跌打损伤发生的原因是直接外力致筋肉受损,血脉破裂,血逸脉外,逸于肌肤之间,积聚成淤,瘀阻气血运行,气血运行不畅,气滞则痛,血瘀则肿,或者间接外伤以及长期劳损的组织,出现了微循环障碍。组织损伤后局部血管通透性增加,水、电解质、血浆蛋白等成分渗入组织间隙,微循环障碍或不畅,引起组织液回流受阻,从而肿胀形成。局部创伤炎性反应、血肿形成、代谢产物堆积,刺激局部神经而产生疼痛。如果不能促使血液沉积物的吸收,就会产生粘连。肌肉、肌腱的粘连会发生缺血性挛缩,关节内外的粘连,就引起了关节的强直。
因此行气活血,提高气化功能,加强局部微循环,是治疗跌打损伤的关键所在。跌打损伤患者普遍存着常规治疗时间长、痛苦,工作、生活都带来不便,甚至有些发展为陈年旧疾,而效果不理想,得不到根治,这是为什么呢?主要是没从根本上加以施治,跌打救苦膏就是从根本上解决这个问题,它的奥秘在哪里?它的奥秘在于能够,散瘀结硬块,生肌长肉,且标本兼治,促使局部血液循环恢复正常功能,达到血肿行气活血化瘀,续筋接骨,消肿止痛、疼痛消失的目的。
发明内容
发明的目的在于提供一种跌打救苦膏及其制备方法,解决了背景技术中的问题。
本发明是这样实现的,一种跌打救苦膏,该跌打救苦膏包括以下中草药原料:
桃仁、红花、生乳香、没药、三棱、莪术、骨碎补、续断、杜仲、当归、白芷、犬片、五加皮、甘草、生地、鸡血藤、血竭、鹿茸、冰片以及麻油。
本发明的进一步技术方案是:所述原料的质量份分别为:桃仁8-12份、红花8-12份、生乳香6-10份、没药8-12份、三棱6-8份、莪术6-8份、骨碎补5-7份、续断5-7份、杜仲5-7份、当归8-12份、白芷8-12份、犬片6-8份、五加皮6-8份、甘草1-3份、生地3-7份、鸡血藤3-7份、血竭3-7份、鹿茸3-7份、冰片1-5份、麻油2-10份。
本发明的进一步技术方案是:所述原料的质量份分别优选:桃仁10份、红花10份、生乳香10份、没药10份、三棱8份、莪术8份、骨碎补7份、续断7份、杜仲7份、当归10份、白芷10份、犬片8份、五加皮8份、甘草3份、生地7份、鸡血藤5份、血竭5份、鹿茸5份、冰片3份、麻油5份。
本发明的进一步技术方案是:所述原料采用上等纯天然中草药的根、茎、叶花、果实、种子、菌类、昆虫或矿物质。
一种跌打救苦膏的制备方法,该制备方法包括以下步骤:
将原料经过清洗,烘干工艺,在无菌、无尘的条件下,用中药粉碎机将中草药分别磨碎,用120目筛进行筛分,按配比掺和混均,研磨成粉状后,再混合搅拌均匀制成软膏即可。
本发明的原料具备的功效如下:活血祛瘀:药物中的桃仁、红花等活性因子能迅速活血逐瘀,祛瘀止痛,有效成分能全面激活受损细胞,使受损的细胞修复再生。
行气活血止痛:药物中的生乳香、没药等活血行气止痛,消肿生肌,有效成分有镇痛、消炎、升高白细胞的作用,并能加速炎症渗出排泄,促进伤口愈合,对真菌有抑制作用。
破血行气,消积止痛:药物中的三棱、我术等破血行气,消积止痛,有效成分对多种癌细胞有直接破坏作用,能通过免疫系统使特异性免疫增强而获得明显的免疫保护效应,从而具有抗癌作用,同时有显著抑制血小板聚集,促进微动脉血流恢复,完全阻止微动脉收缩,明显促进局部微循环恢复,还能降低全血粘度,能抗体外血栓形成,并使血栓时间延长,血栓长度缩短。
补肝肾,强筋骨、托疮毒:药物中的骨碎补、续断、杜仲、鹿茸等有效成分能促进骨对钙的吸收,提高血钙和血磷水平,有利于骨折的愈合,改善软骨细胞,推迟骨细胞的退行性病变,促进组织再生,有调节细胞免疫平衡的功能,能明显改善心脏功能,扩张外周血管,同时能促进毛细血管再生,加速侧肢循环建立,抗氧化衰老,加强微循环的血液循环,促进恢复自我调节功能。
活血止痛、消肿排脓:药方中的当归、白芷有效成分具有兴奋中枢神经的作用,增加冠脉血流量,增强心脏功能,显著促进血红蛋白及红细胞的生成。对患处有止痛,促进血液循环,提高皮肤温度,组织坏死发生、发展,促进创面愈合。
祛风湿,补肝肾,强筋骨:药物中的犬片、五加皮中的有效成分可以有抗炎镇痛、镇静的作用,能增强免疫力,并且有一定的抗排异功能,有较好的止血作用,能促进烫伤、创伤或手术创口不愈所致的体部溃疡的愈合。
活血定痛,舒筋活络,化瘀止血:药物中的生地、鸡血藤、血竭的有效成分具有降压、镇静、抗炎、抗过敏的作用,有缩短凝血时间的作用,能明显增强免疫力还能降低血管阻力,对血小板聚集有明显抑制作用,防止血栓形成,对多种细菌及真菌有抑制作用。
以上原料之间的协同作用使得本发明的效果远远优于单独使用时的效果。具备有益效果中记载的优势。
本发明的有益效果:本发明使用方便,疗效稳定,治疗彻底,无任何毒副作用。跌打救育膏是用二十多种中草药精制而成,主要用于治疗跌打损伤、肩周炎、颈椎病、胶间盘突出、骨质增生、风湿、类风湿性关节炎等疾病。主要优势体现在以下几个方面:
1、打损伤的发病根源入手,针对并发症的转化而研制的,用众多的药对人体全面调节,具有行气血,活血脉,壮筋骨,利关节,除湿痹,舒筋通络,消肿止痛的功效;
2、本着增强心肝肾的功能,抑制肠道过快蠕动,清肠道内的毒素,使肠道的功能恢复。而传统的注射及口服疗法除损伤神经、血管、肌肉等组织和肠道反应,使病人不易接受外,这些方法都易使药物通过全身的血液循环及肠道破,而真正到达疾病局部的药物少之甚微,所以用药量极大,并且疗效极差。而膏药的外治疗法彻底解决了这一难题,药物直接作用于患处,使药效数倍提高,而且不易产生耐药性;
3、本着提高机体免疫力,强刺激通过神经反射,可以调节肌体功能促进抗体形成;
4、本着外用药副作用小,局部吸收迅速的同时,还能调动身体机能有效清除的有害物质,从根本上逆转跌打损伤的发病机制,最后达到康复的目的。
具体实施方式
以下通过特定的具体实例说明本发明的实施方式,本领域技术人员可由本说明书所揭露的内容轻易地了解本发明的其他优点与功效。本发明还可以通过另外不同的具体实施方式加以实施或应用,本说明书中的各项细节也可以基于不同观点与应用,在没有背离本发明的精神下进行各种修饰或改变。
一种跌打救苦膏,该跌打救苦膏包括以下中草药原料:
桃仁、红花、生乳香、没药、三棱、莪术、骨碎补、续断、杜仲、当归、白芷、犬片、五加皮、甘草、生地、鸡血藤、血竭、鹿茸、冰片以及麻油。
所述原料的质量份分别为:桃仁8-12份、红花8-12份、生乳香6-10份、没药8-12份、三棱6-8份、莪术6-8份、骨碎补5-7份、续断5-7份、杜仲5-7份、当归8-12份、白芷8-12份、犬片6-8份、五加皮6-8份、甘草1-3份、生地3-7份、鸡血藤3-7份、血竭3-7份、鹿茸3-7份、冰片1-5份、麻油2-10份。
所述原料的质量份分别优选:桃仁10份、红花10份、生乳香10份、没药10份、三棱8份、莪术8份、骨碎补7份、续断7份、杜仲7份、当归10份、白芷10份、犬片8份、五加皮8份、甘草3份、生地7份、鸡血藤5份、血竭5份、鹿茸5份、冰片3份、麻油5份。
所述原料采用上等纯天然中草药的根、茎、叶花、果实、种子、菌类、昆虫或矿物质。
一种跌打救苦膏的制备方法,该制备方法包括以下步骤:
将原料经过清洗,烘干工艺,在无菌、无尘的条件下,用中药粉碎机将中草药分别磨碎,用120目筛进行筛分,按配比掺和混均,研磨成粉状后,再混合搅拌均匀制成软膏即可。
实施例一:
一种跌打救苦膏,该跌打救苦膏包括以下中草药原料:
桃仁、红花、生乳香、没药、三棱、莪术、骨碎补、续断、杜仲、当归、白芷、犬片、五加皮、甘草、生地、鸡血藤、血竭、鹿茸、冰片以及麻油。
所述原料的质量份分别为:桃仁8份、红花8份、生乳香6份、没药8份、三棱6份、莪术6份、骨碎补5份、续断5份、杜仲5份、当归8份、白芷8份、犬片6份、五加皮6份、甘草2份、生地5份、鸡血藤5份、血竭5份、鹿茸5份、冰片2份、麻油8份。
所述原料采用上等纯天然中草药的根、茎、叶花、果实、种子、菌类、昆虫或矿物质。
一种跌打救苦膏的制备方法,该制备方法包括以下步骤:
将原料经过清洗,烘干工艺,在无菌、无尘的条件下,用中药粉碎机将中草药分别磨碎,用120目筛进行筛分,按配比掺和混均,研磨成粉状后,再混合搅拌均匀制成软膏即可。
实施例二:
一种跌打救苦膏,该跌打救苦膏包括以下中草药原料:
桃仁、红花、生乳香、没药、三棱、莪术、骨碎补、续断、杜仲、当归、白芷、犬片、五加皮、甘草、生地、鸡血藤、血竭、鹿茸、冰片以及麻油。
所述原料的质量份分别优选:桃仁10份、红花10份、生乳香10份、没药10份、三棱8份、莪术8份、骨碎补7份、续断7份、杜仲7份、当归10份、白芷10份、犬片8份、五加皮8份、甘草3份、生地7份、鸡血藤5份、血竭5份、鹿茸5份、冰片3份、麻油5份。
所述原料采用上等纯天然中草药的根、茎、叶花、果实、种子、菌类、昆虫或矿物质。
一种跌打救苦膏的制备方法,该制备方法包括以下步骤:
将原料经过清洗,烘干工艺,在无菌、无尘的条件下,用中药粉碎机将中草药分别磨碎,用120目筛进行筛分,按配比掺和混均,研磨成粉状后,再混合搅拌均匀制成软膏即可。
实施例三:
一种跌打救苦膏,该跌打救苦膏包括以下中草药原料:
桃仁、红花、生乳香、没药、三棱、莪术、骨碎补、续断、杜仲、当归、白芷、犬片、五加皮、甘草、生地、鸡血藤、血竭、鹿茸、冰片以及麻油。
所述原料的质量份分别为:桃仁12份、红花12份、生乳香10份、没药12份、三棱8份、莪术8份、骨碎补7份、续断7份、杜仲7份、当归12份、白芷12份、犬片8份、五加皮8份、甘草3份、生地7份、鸡血藤7份、血竭7份、鹿茸7份、冰片5份、麻油10份。
所述原料采用上等纯天然中草药的根、茎、叶花、果实、种子、菌类、昆虫或矿物质。
一种跌打救苦膏的制备方法,该制备方法包括以下步骤:
将原料经过清洗,烘干工艺,在无菌、无尘的条件下,用中药粉碎机将中草药分别磨碎,用120目筛进行筛分,按配比掺和混均,研磨成粉状后,再混合搅拌均匀制成软膏即可。
对跌打损伤病的治疗主要体现在及时消除红肿和缓解疼痛,也是各脏腑全面调节的一个过程,直接贴敷于体表穴位上,药性透过皮毛媵理由表入里,渗透达皮下组织,一方面在局部产生药物浓度的相对优势:另方面可通过经络的贯通运行,直达脏腑失调经气失调的病所,发挥药物“归经”和功能效应,从而发挥最大的全身药理效应。跌打救苦膏是对跌打损伤及各脏腑全面调节,通过调节肝脾肾的功能使人体正常的过程,对心肝肾功能改善更加明显,是治疗跌打损伤及为难得的一种的好药。跌打损伤患者在使用跌打救苦膏2-3个疗程后(1个疗程为1周),药物中的有效活性分子进入血液,直达病变部位,在治疗跌打损伤过程中,以活血化瘀,消肿止痛为主,逐步控制跌打损伤的发病机制,调节人体肝脾肾的运化,起到协调与综合治疗作用,从根本上彻底逆转跌打损伤发病机制,使身体达到康复的目的。跌打救苦膏是从跌打损伤的发病根源入手,起到恢复人体局部微循环的功能和整体调治并发症等多重功效。跌打救苦膏具有以下五大特点:
1、标本兼治。它突破传统的治疗局限,该药在治疗跌打损伤的同时还全面调节各脏腑,不仅有传统止痛消肿的作用,以人体经络穴位为贴用部位,通过调节各经络穴位,调整各脏腑的失调,对心肝肾功能改善更加明显。
2、同时贴于体表的膏药通过皮肤渗透达皮下组织,在局部产生药物浓度的相对优势,从而发挥较强的药理作用,刺激神经末梢,通过反射,扩张血管,促进局部血液循环,改善周围组织营养,对创伤,皮肤疾病,黏膜病变的治疗,均有消炎止痛等局部作用,从而达到消肿、消炎等作用。
3、有些刺激性强的药物,强刺激通过神经反射,可以调节肌体功能促进抗体形成,提高人体免疫力。同时,药物穿通皮肤及黏膜后,经过血管或淋巴管进入体循环,可产生全身性药物作用,达到治疗疾病的目的。
4、众药综治打破常规战术,它是用多种药物,全面出击,具有行气血,活血脉,壮筋骨,利关节,除湿痹,舒筋通络,消肿止痛的功效。
5、彻底根治。不需长期用药,当药物中的活性分子进入人体后,改善局部微循环后,使其趋于正常。外用3-4个疗程,局部软组织功能康复,加以巩固、脱离药物且不反弹,处于健康状态。
跌打损伤的病因较为复杂,应以实为纲,不同的病因病症,确立相应的治疗法则在整个治疗跌打损伤的过程中,必须行气活血化瘀,消肿止痛。这是治疗跌打损伤的有效途径,在众多的药物中,各种药在体内起到各自的作用,单靠某种药物治疗或几味药物治一疗,效果不理想。用药如用兵,必须把人体看成是一个有机整体,逆转其病理机制,防止并发症的产生,从而步入根本治疗、整体恢复,标本兼治的最佳治疗境界。
根据跌打损伤的病因病理,该药以行气活血化瘀,消肿止痛为主,对各脏器全面调理,辨清虚实,做到活血祛瘀,通经,消肿生肌,消积止痛,疗伤续折,舒筋活络,补肝肾,强腰膝,祛风湿。这是全方位调理人体的综合疗法。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (5)
1.一种跌打救苦膏,其特征在于:该跌打救苦膏包括以下中草药原料:
桃仁、红花、生乳香、没药、三棱、莪术、骨碎补、续断、杜仲、当归、白芷、犬片、五加皮、甘草、生地、鸡血藤、血竭、鹿茸、冰片以及麻油。
2.根据权利要求1所述的一种跌打救苦膏,其特征在于:所述原料的质量份分别为:桃仁8-12份、红花8-12份、生乳香6-10份、没药8-12份、三棱6-8份、莪术6-8份、骨碎补5-7份、续断5-7份、杜仲5-7份、当归8-12份、白芷8-12份、犬片6-8份、五加皮6-8份、甘草1-3份、生地3-7份、鸡血藤3-7份、血竭3-7份、鹿茸3-7份、冰片1-5份、麻油2-10份。
3.根据权利要求2所述的一种跌打救苦膏,其特征在于:所述原料的质量份分别优选:桃仁10份、红花10份、生乳香10份、没药10份、三棱8份、莪术8份、骨碎补7份、续断7份、杜仲7份、当归10份、白芷10份、犬片8份、五加皮8份、甘草3份、生地7份、鸡血藤5份、血竭5份、鹿茸5份、冰片3份、麻油5份。
4.根据权利要求1-3任意一项所述的一种跌打救苦膏,其特征在于:所述原料采用上等纯天然中草药的根、茎、叶花、果实、种子、菌类、昆虫或矿物质。
5.根据权利要求4所述的一种跌打救苦膏的制备方法,其特征在于:该制备方法包括以下步骤:
将原料经过清洗,烘干工艺,在无菌、无尘的条件下,用中药粉碎机将中草药分别磨碎,用120目筛进行筛分,按配比掺和混均,研磨成粉状后,再混合搅拌均匀制成软膏即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011474394.6A CN112451641A (zh) | 2020-12-14 | 2020-12-14 | 一种跌打救苦膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011474394.6A CN112451641A (zh) | 2020-12-14 | 2020-12-14 | 一种跌打救苦膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112451641A true CN112451641A (zh) | 2021-03-09 |
Family
ID=74804299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011474394.6A Pending CN112451641A (zh) | 2020-12-14 | 2020-12-14 | 一种跌打救苦膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112451641A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101062180A (zh) * | 2007-05-21 | 2007-10-31 | 王军 | 当归跌打散 |
CN101744960A (zh) * | 2008-12-08 | 2010-06-23 | 徐泽三 | 血竭三七接骨膏及其制备方法 |
CN107970341A (zh) * | 2017-12-07 | 2018-05-01 | 常州市天宁区鑫发织造有限公司 | 一种三七接骨凝胶膏剂 |
-
2020
- 2020-12-14 CN CN202011474394.6A patent/CN112451641A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101062180A (zh) * | 2007-05-21 | 2007-10-31 | 王军 | 当归跌打散 |
CN101744960A (zh) * | 2008-12-08 | 2010-06-23 | 徐泽三 | 血竭三七接骨膏及其制备方法 |
CN107970341A (zh) * | 2017-12-07 | 2018-05-01 | 常州市天宁区鑫发织造有限公司 | 一种三七接骨凝胶膏剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104189871A (zh) | 一种治疗骨质增生的药酒 | |
CN107095982A (zh) | 一种熥敷药剂及其制备方法 | |
CN109700856A (zh) | 一种具有活血通络、舒筋止痛的中药外用方剂 | |
CN112451641A (zh) | 一种跌打救苦膏及其制备方法 | |
CN103223078A (zh) | 用离子导入治疗膝关节骨性关节炎的中药 | |
CN105816755A (zh) | 一种治疗腰椎、颈椎风湿骨病的乌龙通痹丸 | |
CN102526382B (zh) | 一种消肿止痛的膏药 | |
CN111329921A (zh) | 治疗筋骨疼痛的中药组合物及其药物、制备方法与应用 | |
CN105031156A (zh) | 一种治疗跌打膏药 | |
CN105497779A (zh) | 用于治疗急性腰扭伤的中药膏药 | |
CN104491324A (zh) | 一种患者术后用活血通络气雾剂 | |
CN101195002B (zh) | 祛痛保健中药贴膏 | |
CN109908245A (zh) | 一种用于治疗颈肩腰腿痛病的中药组合物 | |
CN110038101A (zh) | 一种中药祛痛止痒外用制剂及其制备方法 | |
CN104189334A (zh) | 一种治疗肌腱撕裂损伤的药膏 | |
CN104324108B (zh) | 治疗膝关节骨性关节炎(着痹)的外用中药组合物 | |
CN109010549A (zh) | 接骨祛风活血止痛膏及其制备方法 | |
CN1075730C (zh) | 祛风通络拔毒散 | |
CN104173765B (zh) | 温热渗透治疗修复运动损伤的中药制剂和药包 | |
CN101313944B (zh) | 百草疼痛渗透液 | |
CN106421410A (zh) | 一种治疗糖尿病足的中药组合物 | |
CN105147938A (zh) | 一种治疗严重软组织损伤的中药制剂 | |
CN105560427A (zh) | 一种透皮通关散 | |
CN104435329A (zh) | 一种治疗跟骨高压症的中药组合物 | |
CN105434818A (zh) | 治疗颈椎病的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210309 |
|
RJ01 | Rejection of invention patent application after publication |